Powder Delivery TRIZ Cases

A stable dry powder formulation combines tiotropium bromide, fluticasone propionate, and sodium cromoglycate for pulmonary delivery.

Functionalized magnetic nanoparticles apply mechanical force to reactivate dysfunctional T cells, reducing side effects from non-specific cancer treatments.

mPEG-PLA-Phe(Boc) polymer micelles resolve low blood cell counts in bone marrow suppression by improving sanguisorbigenin solubility.

Orodispersible tablets stabilize thermally sensitive burlulipase, eliminating large pancreatin doses and complex cooling requirements.

CendR elements utilize proteolytic cleavage to achieve selective internalization, overcoming non-specific uptake in tumor environments.

Microlayer coextrusion generates nanometer-scale layered polymers that resolve the trade-off between processing ease and sustained drug release reliability.

Anatase titanium dioxide on functionalized carbon nanotubes absorbs UV-A light to generate cytotoxic effects in tumor cells.

PLGA microparticles with specific viscosity and size ranges achieve continuous slow release of water insoluble peptide salts for more than six months.

Suberic acid regulates mTORC signaling to boost muscle mass while simplifying formulation complexity compared to multi-component treatments.

Mesoporous silica excipients entrap amorphous active ingredients within nanopores to enhance dissolution rates.

An implantable composition releases analgesics gradually through a biocompatible polymer matrix.

Introducing a cationic DOTAP intermediary prevents negative-negative repulsion, stopping nanocapsule agglomeration and active moiety leakage.

A retinoid-based carrier delivers therapeutic agents to extracellular matrix-producing cells in the kidney.

A crosslinked copolymer thickener maintains viscosity in aqueous compositions through tailored monomer ratios.

Multilayer polyelectrolyte films deposit oppositely charged RSV epitopes onto microparticles, avoiding harmful Th2-dominant inflammatory responses.

Cross-linked copolymers stabilize nucleic acid cargo through imine bonds, reducing cytotoxicity while maintaining transfection efficiency.

Polyhydroxyalkanoate nanoparticles encapsulate gold nanorods and magnetic particles to deliver theranostic agents without systemic toxicity.

Metallic core nanoparticles bind to over-expressed proteins on cancer cells to induce localized thermal damage.

Hydrophilic polymer strands cross-link to form sustained release formulations for biologic therapeutics.

Hydrophobically modified resins adsorb betalains from liquid extracts, removing hygroscopic impurities to prevent clumping and ensure complete water solubility.

Co-lyophilization generates mixed particles from low and high abundance components, preventing aggregation and maintaining serum supplement activity.

Extruded silicic acid carriers prevent gel formation while avoiding capsule deformation caused by hygroscopic stabilizers.

Sterilized and desalted amniotic fluid reduces scar formation while enhancing wound healing rates.

Oral gamma-hydroxybutyrate composition uses pH buffering to maintain bioequivalence despite food-induced absorption reduction.

Polyethylene glycol coatings minimize adhesive interactions, enabling rapid diffusion of large nanoparticles through the brain extracellular space.

Nitrogen-rich surface layer on resorbable glass matrix retains radioisotopes, eliminating surgical removal and MRI interference.

Lipid multiparticulate compositions combine low and high flow point excipients to resolve bioavailability stability trade-offs in carotenoid delivery.

Segmented dosing protocols simplify complex regimens, reducing implementation barriers while maintaining allergy prevention effectiveness.

Fluorescent phosphor integrated dots replace subjective DAB staining to quantify antibody-drug conjugate expression levels with high precision.

A driven roller deposits powder into web microdepressions via controlled surface speed, resolving complex metering challenges.

Specific amino acid substitutions in anti-CD38 antibody chains resolve thermal instability while maintaining cytotoxic activity.

Pharmaceutical composition with 3-(arylsulfonyl)propanenitrile inhibits pro-inflammatory cytokine release.

Insoluble granule cores combined with embittering agents resist solvent extraction and crushing, preventing drug misuse while maintaining therapeutic efficacy.

A respiratory system delivers medicaments under positive pressure using a pressure-sensitive switch to activate the nebulizer during inspiration.

Hydrothermal treatment transforms calcium phosphate grains into needles to increase specific surface area and protein adsorption capacity.

Segmented nanotube components hybridize at tumor sites to deliver payloads, reducing systemic toxicity while maintaining high targeting reliability.

Hybrid nanoparticles merge semiconductor light emission with magnetic properties via a silica shell coating for stable biological applications.

Oral omega-3 fatty acid amide formulations reduce triglyceride levels without raising LDL cholesterol.

Administering P2X3 receptor antagonists blocks venom-induced pain pathways, resolving ineffective conventional thermal treatments.

Combining decanoic acid with perampanel creates synergistic AMPA receptor inhibition to control seizure activity in epilepsy patients.

Silica-shelled fluorescent nanoparticles enable precise tissue marking and deep-penetration imaging through near-infrared emission.

Zwitterionic pendant groups on the polymer backbone resist non-specific protein adsorption while maintaining tailored hydrophobic-hydrophilic balance.

Segmented peptides with non-hydrolyzable lipid moieties enable efficient nanoparticle release from endocytic vesicles while preserving cellular integrity.

Interconnected porous polymer structure sustains bioactive molecule release over time, resolving toxicity risks from covalent immobilization methods.

A single-step photochemical method produces monodisperse gold nanoparticles using a thioxanthone derivative as both photoinitiator and stabilizer.

Pre-functionalizing polymer scaffolds with biotinylated or click chemistry reagents distributes reactive handles throughout the matrix before assembly.

An engineered receptor-ligand system transports therapeutic agents across biological barriers.

Engineered HCV E2 core polypeptides displayed on self-assembling nanoparticles to induce robust neutralizing antibody responses.